Hearing Instruments for Hearing Loss
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how different hearing aids can improve speech understanding and reduce listening effort for individuals with hearing loss. Researchers aim to determine if certain hearing aids perform better than others. Participants will try three different hearing aid models and engage in lab activities to assess their speech comprehension and listening ease. Individuals with significant hearing loss (N3 or N4) who already use hearing aids may be suitable for this trial. As an unphased trial, it offers participants the chance to contribute to valuable research that could enhance hearing aid technology for future users.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these hearing instruments are safe for use in adults with hearing loss?
Research shows that hearing aids are generally safe for people with hearing loss. Studies have found that older adults using hearing aids often communicate better and express high satisfaction with their devices, indicating that hearing aids are usually well-accepted.
Major reports of problems directly caused by these devices have not emerged. This likely results from the non-invasive nature of hearing aids, as they do not involve surgery or enter the body. They simply amplify sounds, aiding in speech comprehension and making listening easier, without any known serious health risks.
For those considering joining a trial for hearing aids, current research suggests they are safe and can significantly improve hearing and communication.12345Why are researchers excited about this trial?
Researchers are excited about these hearing instruments because they aim to offer a more personalized and effective solution for individuals with hearing loss. Unlike traditional hearing aids, which often rely on a one-size-fits-all approach, this trial is exploring three different models of hearing instruments to tailor the experience to individual needs. By testing these models without users knowing which one they're using, the goal is to identify subtle differences in performance that could enhance user satisfaction and auditory outcomes. This approach could lead to more precise fitting and better hearing experiences for those with hearing impairments.
What evidence suggests that hearing instruments are effective for hearing loss?
Studies have shown that hearing aids can greatly enhance communication for people with hearing loss. Research indicates that the methods of providing hearing aids and the technology used can influence their effectiveness, with some options yielding better results. One study found that regular hearing aid users tend to live longer than non-users. Additionally, users report greater satisfaction and improved hearing with hearing aids. Overall, hearing aids help people hear and communicate more effectively in their daily lives.56789
Are You a Good Fit for This Trial?
Adults with bilateral hearing loss are eligible for this trial. They will test different hearing instruments to see if they help understand speech better and reduce the effort needed to listen. Participants must be willing to wear various models and engage in lab activities.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are fitted with varying models of hearing instruments and participate in lab-based activities to evaluate speech understanding, listening effort, and subjective preference
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Hearing Instruments
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sonova AG
Lead Sponsor
Arnd Kaldowski
Sonova AG
Chief Executive Officer since 2018
MBA from INSEAD, MSc in Mechanical Engineering from ETH Zurich
Stefan Launer
Sonova AG
Chief Medical Officer since 2016
PhD in Natural Sciences from ETH Zurich
University of South Florida
Collaborator